Login

Erik Kinnman, CEO, NeuroVive Pharmaceutical 00:00:00

Share On Facebook Share On Twitter

NeuroVive Pharmaceutical - Company presentation

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Evolution Energy Minerals: Developing Chilalo Graphite Project in Tanzania
00:10:00
Il Capitale Naturale: Preservazione e Rigenerazione con Lombard Odier Investment Managers
00:10:00
DECA Games' 80% Revenue Surge via Alternative App Stores | Jens Lauritzson , CEO of Flexion Mobile Plc
00:10:00
Commerzbank's Strategy Amid Germany's Economic Challenges | Manfred Knof , CEO ,  Commerzbank.
00:10:00
committed to investing patiently in developing new ways to live eat travel and build|Bill Gates,Founder,Breakthrough Energy Ventures
00:10:00
Thomas Peterffy, Chairman of Interactive Brokers, discusses the company's quarterly earnings on "Closing Bell Overtime."
00:10:00
T&T Power Group: Delivering Customized Generator Solutions with a Customer-Centric Approach
00:10:00
Exploring the Financial Cold War: Insights from James Fok's Book
00:10:00
Newcore Gold's Luke Alexander Discusses De-risking and Project Advancements in Ghana | Luke Alexander - President, CEO & Director of Newcore Gold Ltd.
00:10:00
Crafting a Successful Exit Plan with Brooklyn Brock |Brooklyn Brock, President, Ellevate Advisors LLC.
00:10:00
Patent Wars: Facebook's IP Risks and Strategic Responses
00:10:00
The principals of Somers Investment Partners were formerly with predecessor firm SV Investment Partners|NICHOLAS SOMERS, Managing Partner,SV Investment Partners

© 2017 - Neuhu+